Chemo India Formulation is a finished-dose manufacturer based in India. It appears in 9 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), INVIMA (CO) and DIGEMAPS (DO). Its GMP standing is certified by EMA. Customs aggregates show $3.7M of exports covering 665 molecules to 13 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Hyderabad, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 3 | None |
| INVIMA (CO) | 3 | None |
| DIGEMAPS (DO) | 3 | None |
| EMA | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.4M | 7 |
| 2025 | Not reported | $3.7M | 13 |
| 2024 | Not reported | $1.8M | 8 |
| 2023 | Not reported | $2.5M | 5 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Chemo India Formulation comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.